TARA MEYER: Open Payments
NPI 1588664981 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$909 in 43 payments from 10 companies in 2025. Trend: 2023 $899 · 2024 $1,064 · 2025 $909
Food & beverage: $909
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $243 |
| Madrigal Pharmaceuticals | 11 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $126 |
| GENZYME CORPORATION | 4 | $109 |
| Janssen Biotech, Inc. | 4 | $74 |
| Medtronic, Inc. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $32 |
| Intercept Pharmaceuticals, Inc. | 1 | $23 |
| Celltrion USA Inc. | 1 | $23 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, ENTYVIO, CREON, RINVOQ, EOHILIA, SKYRIZI.
Industry payments across PA — which companies pay providers there.
